Utility of a New Targeted Next Generation Sequencing Test for Liquid Biopsy Samples from Patients with NSCLC
Presented by: Dr. Hestia MellertSenior Director, DevelopmentBiodesix
A leading data-driven diagnostic solutions company helping answer critical clinical questions faced by physicians, researchers, and biopharmaceutical companies, with a primary focus in lung disease.
2970 Wilderness Place, Suite 100 Boulder, CO 80301
© Copyright 2021 Biodesix. All Rights Reserved.